Author

Patrik Foerch

UCB Pharma (Belgium)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:protein sequence· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Albert Chung· 1 shared Andrée Delahaye‐DurieziD· 1 shared Bénédicte Danis· 1 shared Benjamin M. J. OwensiD· 1 shared Carlo FisicaroiD· 1 shared Catherine Vandenplas· 1 shared Enrico G. PetrettoiD· 1 shared Fabio AiroldiiD· 1 shared

Activity by Year

2017-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

Albert Chung

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiophysicsbioRxivPreprintJun 15, 2024

Improving Inverse Folding models at Protein Stability Prediction without additional Training or Data

Oliver Dutton, Sandro Bottaro, Michele Invernizzi…·Kamil Tamiola

The paper improves protein stability prediction by modifying existing models with a self-derived term, enhancing their performance without additional training or data.

8 citations

protein sequencedeep learning

Systems BiologybioRxivPreprintMay 22, 2017

A Systems-Level Framework For Drug Discovery Identifies Csf1R As A Novel Anti-Epileptic Drug Target

Prashant Kumar Srivastava, Jonathan M. van Eyll, Patrice Godard…·Michael R. Johnson

This paper introduces CRAFT, a computational framework for drug target identification, and validates Csf1R as a novel anti-epileptic target using pre-clinical models.

3 citations

statistical modeldrug response / drug discovery